Cellular and viral determinants that regulate HIV-1 infection in macrophages
- PMID: 8083600
- DOI: 10.1002/jlb.56.3.278
Cellular and viral determinants that regulate HIV-1 infection in macrophages
Abstract
Macrophages in brain, lung, and lymphatics constitute a major HIV reservoir during subclinical infection and disease. During HIV transmission macrophages are seemingly one of the first cells infected, being as efficient as T cells in supporting productive viral replication. Macrophages control a myriad of cell-mediated immune responses that regulate the levels of infection and lead to viral persistence. HIV determinants control viral entry and productive replication and, taken together with cellular differentiation factors, decide the outcome of virus-macrophage interactions. Most important, many clinical manifestations of HIV infection such as encephalitis, myelopathy, pneumonitis, and lymphadenopathy are closely linked to viral replication. Indeed, tissue pathology often correlates with viral gene expression in tissue macrophages. Taken together, these observations provide strong support for a central role of macrophages in progressive HIV infection and its clinical manifestations.
Similar articles
-
Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections.J Virol. 2016 Aug 12;90(17):7596-606. doi: 10.1128/JVI.00672-16. Print 2016 Sep 1. J Virol. 2016. PMID: 27307568 Free PMC article. Review.
-
Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.J Virol. 2016 May 27;90(12):5643-5656. doi: 10.1128/JVI.00290-16. Print 2016 Jun 15. J Virol. 2016. PMID: 27030272 Free PMC article.
-
Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms.Ann Neurol. 1993 May;33(5):429-36. doi: 10.1002/ana.410330502. Ann Neurol. 1993. PMID: 8498818 Review.
-
Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages.Proc Natl Acad Sci U S A. 1989 May;86(9):3337-41. doi: 10.1073/pnas.86.9.3337. Proc Natl Acad Sci U S A. 1989. PMID: 2717618 Free PMC article.
-
Viral and host cofactors facilitate HIV-1 replication in macrophages.J Leukoc Biol. 2003 Nov;74(5):726-35. doi: 10.1189/jlb.0503220. Epub 2003 Jul 22. J Leukoc Biol. 2003. PMID: 12960226 Review.
Cited by
-
Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.Neurotox Res. 2012 Jan;21(1):79-89. doi: 10.1007/s12640-011-9279-2. Epub 2011 Sep 27. Neurotox Res. 2012. PMID: 21948112 Free PMC article. Review.
-
HIV-1 uses dynamic podosomes for entry into macrophages.J Virol. 2021 Apr 26;95(10):e02480-20. doi: 10.1128/JVI.02480-20. Epub 2021 Feb 24. J Virol. 2021. PMID: 33627394 Free PMC article.
-
Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages.Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):9004-8. doi: 10.1073/pnas.92.19.9004. Proc Natl Acad Sci U S A. 1995. PMID: 7568061 Free PMC article.
-
Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.J Virol. 2002 Feb;76(4):1697-706. doi: 10.1128/jvi.76.4.1697-1706.2002. J Virol. 2002. PMID: 11799165 Free PMC article.
-
Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.J Virol. 1996 Aug;70(8):5487-94. doi: 10.1128/JVI.70.8.5487-5494.1996. J Virol. 1996. PMID: 8764060 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical